Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.
BMC Womens Health. 2021 Oct 28;21(1):375. doi: 10.1186/s12905-021-01475-2.
BMC Womens Health. 2021.
PMID: 34711224
Free PMC article.
Clinical Trial.
Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results.
Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N.
Osuga Y, et al. Among authors: seki y.
BMC Womens Health. 2021 Jun 21;21(1):250. doi: 10.1186/s12905-021-01393-3.
BMC Womens Health. 2021.
PMID: 34154590
Free PMC article.
Clinical Trial.
Item in Clipboard
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study.
Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N.
Osuga Y, et al. Among authors: seki y.
Fertil Steril. 2021 Feb;115(2):397-405. doi: 10.1016/j.fertnstert.2020.07.055. Epub 2020 Sep 7.
Fertil Steril. 2021.
PMID: 32912633
Free article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: An open-label, phase 3 exploratory study.
Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K.
Inagaki N, et al. Among authors: seki y.
J Diabetes Investig. 2018 Mar;9(2):354-359. doi: 10.1111/jdi.12730. Epub 2017 Oct 30.
J Diabetes Investig. 2018.
PMID: 28836351
Free PMC article.
Clinical Trial.
Item in Clipboard
Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 study.
Inagaki N, Sano H, Seki Y, Kuroda S, Kaku K.
Inagaki N, et al. Among authors: seki y.
J Diabetes Investig. 2016 Sep;7(5):718-26. doi: 10.1111/jdi.12499. Epub 2016 Mar 28.
J Diabetes Investig. 2016.
PMID: 27181699
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite